LCM
ALT icon

Laurion Capital Management’s Altimmune ALT Stock Holding History

Laurion Capital Management’s Portfolio ALT Stock Details ALT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-809,685
Closed -$2.11M – 473
2023
Q3 		$2.11M Sell
809,685
-1,029,919
-56% -$2.95M 0.01% 334
2023
Q2 		$6.49M Sell
1,839,604
-1,661,726
-47% -$7.46M 0.04% 245
2023
Q1 		$14.8M Buy
3,501,330
+2,750,030
+366% +$32.7M 0.1% 177
2022
Q4 		$12.4M Buy
751,300
+1,195
+0.2% +$13.4K 0.06% 213
2022
Q3 		$9.58M Sell
750,105
-13,865
-2% -$205K 0.06% 192
2022
Q2 		$8.94M Buy
+763,970
New +$4.71M 0.14% 119

Other funds holding ALT

Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TIM
Timelo Investment Management Aurora, Ontario, Canada $349M AUM 28.06% 1-Year Est. Return

Laurion Capital Management's ALT Position: Q4 2023 in Review

Laurion Capital Management sold out of Altimmune (ALT) in Q4 2023, closing a stake of 809,685 shares — an estimated $2.11M sold.

Laurion Capital Management first reported a position in ALT in Q2 2022 and held it in 6 quarters. The position peaked at $14.8M in Q1 2023. 143 funds tracked by Wall St. Rank hold ALT as of Q4 2023.

  • Laurion Capital Management reported no remaining Altimmune position as of Q4 2023 after selling out during the quarter.
  • Laurion Capital Management sold 809,685 Altimmune shares in Q4 2023, an estimated $2.11M.
  • Laurion Capital Management first reported a position in Altimmune in Q2 2022 and held it in 6 quarters.
  • Laurion Capital Management's Altimmune position peaked at $14.8M in Q1 2023.
  • 143 funds tracked by Wall St. Rank held Altimmune as of Q4 2023.

Based on Laurion Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.